Skip to main content

Enabling NAnomedicine TRANSlation

Objective

ENATRANS’ main objective is to network and support SMEs in translation of nanomedicine in Europe by providing a one-stop-shop service to interact and share information, experience and advice with up-to-date information and interactive tools, but also enabling personal contacts.
To be successful SMEs need to understand the requirements of the complex ecosystem made up of regulatory and reimbursement agencies, as well as the requirements of large industrial companies and clinical needs. ENATRANS will gather and provide information about approval processes, regulatory authorities and agencies, clinical and market data, and specific nanomedicine value chain analysis, relevant SME support projects and organisations. ENATRANS will convert this critical information in dedicated learning programs and tools dedicated to translation of nanomedicine.
ENATRANS aims at implementing the concept of a Translation Advisory Board (TAB) as central element of the ETPN White Paper. A TAB will be set-up with senior experienced translation experts to guide R&D teams (in SMEs and research institutes) along the translation process to successfully make it to clinical trials and later to the market.
Promising projects identified and supported by the TAB need access to clinical centers for first studies in patients, which are able to handle the specificity of new nanotechnology based therapeutics. In addition, financial resources are needed to go pass the regulatory and scale-up processes, which often require funding from investors and/or large companies. ENATRANS will build bridges to clinical trial centers, investors and large companies.
Promising projects need guidance to successfully master privileged contacts with the medical, the business or the investment community. ENATRANS will deliver special coaching sessions prior to showcasing of promising projects.
Partners in ENATRANS are VDI/VDE-IT, Nanobiotix, CEA, bioanalytik-muenster, Tel Aviv University, Fondazione Don Gnocchi, TecMinho.

Field of science

  • /social sciences/economics and business/business and management/commerce
  • /medical and health sciences/medical biotechnology/nanomedicine

Call for proposal

H2020-NMP-CSA-2014
See other projects for this call

Funding Scheme

CSA - Coordination and support action

Coordinator

VDI/VDE INNOVATION + TECHNIK GMBH
Address
Steinplatz 1
10623 Berlin
Germany
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 461 050

Participants (6)

NANOBIOTIX SA
France
EU contribution
€ 408 250
Address
Rue De Wattignies, Batiment B 60
75012 Paris
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
France
EU contribution
€ 287 750
Address
Rue Leblanc 25
75015 Paris 15
Activity type
Research Organisations
GESELLSCHAFT FUR BIOANALYTIK MUNSTER EV
Germany
EU contribution
€ 233 125
Address
Mendelstrasse 11
48149 Munster
Activity type
Research Organisations
TEL AVIV UNIVERSITY
Israel
EU contribution
€ 163 750
Address
Ramat Aviv
69978 Tel Aviv
Activity type
Higher or Secondary Education Establishments
FONDAZIONE DON CARLO GNOCCHI ONLUS
Italy
EU contribution
€ 131 250
Address
Piazzale Rodolfo Morandi 6
20148 Milano
Activity type
Research Organisations
ASSOCIACAO UNIVERSIDADE EMPRESA PARA DESENVOLVIMENTO TECMINHO
Portugal
EU contribution
€ 314 231
Address
Campus De Azurem Universidade Do Minho
4800 058 Guimaraes
Activity type
Other